Inventaire - your friends and communities are your best library

Cellular APOBEC3G restricts HIV-1 infection in resting CD4+ T cells

published in: Nature

date of publication: 2005-04-13

language: English

main subject: HIV

Cites articles 28

Date

Title

Authors

2005-01-01

Antiviral function of APOBEC3G can be dissociated from cytidine deaminase activity

Michael Henry Malim
2004-05-01

Characterization of restrictions to human immunodeficiency virus type 1 infection of monocytes
2004-03-01

Inhibition of hepatitis B virus replication by APOBEC3G

Bastien Mangeat
2004-08-01

Cytidine deamination of retroviral DNA by diverse APOBEC proteins

Soo-Jin Cho, Michael Henry Malim
2004-08-10

APOBEC3F properties and hypermutation preferences indicate activity against HIV-1 in vivo

Reuben S Harris
2004-06-16

A second human antiretroviral factor, APOBEC3F, is suppressed by the HIV-1 and HIV-2 Vif proteins

Bryan R. Cullen, Hal P Bogerd, Heather L Wiegand
2004-06-01

Human APOBEC3F is another host factor that blocks human immunodeficiency virus type 1 replication

Kenzo Tokunaga, Tetsutaro Sata
2004-02-26

The cytoplasmic body component TRIM5alpha restricts HIV-1 infection in Old World monkeys

Joseph Sodroski
2003-06-13

DNA deamination mediates innate immunity to retroviral infection

Michael Henry Malim, Reuben S Harris
2003-07-03

Broad antiretroviral defence by human APOBEC3G through lethal editing of nascent reverse transcripts
2003-05-16

Hypermutation of HIV-1 DNA in the absence of the Vif protein,Hypermutation of HIV-1 DNA in the Absence of the Vif Protein

François Clavel, Allan J Hance
2003-07-03

The cytidine deaminase CEM15 induces hypermutation in newly synthesized HIV-1 DNA

Roger J. Pomerantz
2003-09

HIV-1 Vif blocks the antiviral activity of APOBEC3G by impairing both its translation and intracellular stability
2003-11

HIV-1 Vif protein binds the editing enzyme APOBEC3G and induces its degradation
2003-11

The antiretroviral enzyme APOBEC3G is degraded by the proteasome in response to HIV-1 Vif
2003-07-11

Species-specific exclusion of APOBEC3G from HIV-1 virions by Vif

Renate König, Carsten Münk
2003-04-01

Activation-induced cytidine deaminase deaminates deoxycytidine on single-stranded DNA but requires the action of RNase

Matthew D Scharff
2003-11-07

Induction of APOBEC3G ubiquitination and degradation by an HIV-1 Vif-Cul5-SCF complex
2003-12-18

The gene product Murr1 restricts HIV-1 replication in resting CD4+ lymphocytes

Cisca Wijmenga, Ezra Burstein, John R. Mascola, Gary Nabel, Mark K. Louder
2002-09-01

Molecular characterization of preintegration latency in human immunodeficiency virus type 1 infection

Christopher B. Buck, Theodore C Pierson, Robert F. Siliciano
2002-08-08

Isolation of a human gene that inhibits HIV-1 infection and is suppressed by the viral Vif protein

Nathan Gaddis, Michael Henry Malim
2002-03

An anthropoid-specific locus of orphan C to U RNA-editing enzymes on chromosome 22

Ian Dunham, James Scott
2002-11-01

RNA editing enzyme APOBEC1 and some of its homologs can act as DNA mutators

Reuben S Harris
2001-04-01

Molecular mechanisms of apolipoprotein B mRNA editing
2001-10-01

HIV-1 actively replicates in naive CD4(+) T cells residing within human lymphoid tissues
2000-09-01

Class switch recombination and hypermutation require activation-induced cytidine deaminase (AID), a potential RNA editing enzyme

Tasuku Honjo
1998-04-01

Progression to the G1b phase of the cell cycle is required for completion of human immunodeficiency virus type 1 reverse transcription in T cells
1990-04-20

HIV-1 entry into quiescent primary lymphocytes: molecular analysis reveals a labile, latent viral structure

Article - wd:Q40435387

Welcome to Inventaire

the library of your friends and communities

learn more